Differences in the case fatality risks associated with SARS-CoV-2 Delta and non-Delta variants in relation to vaccine coverage: An early ecological study in the United Kingdom
Open Access
- 27 November 2021
- journal article
- research article
- Published by Elsevier BV in Infection, Genetics and Evolution
- Vol. 97, 105162
- https://doi.org/10.1016/j.meegid.2021.105162
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31871340, 71974165)
- Food and Health Bureau (4054456, COVID190103, PIEF/Ph2/COVID/06)
- Health and Medical Research Fund (INF-CUHK-1)
This publication has 6 references indexed in Scilit:
- Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021Eurosurveillance, 2021
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationNature, 2021
- Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 VaccineesClinical Infectious Diseases, 2021
- Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomesThe Lancet Infectious Diseases, 2021
- Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2Viruses, 2021